Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer
Khorana, Alok A, Soff, Gerald A, Kakkar, Ajay K, Vadhan-Raj, Saroj, Riess, Hanno, Wun, Ted, Streiff, Michael B, Garcia, David A, Liebman, Howard A, Belani, Chandra P, O’Reilly, Eileen M, Patel, Jai N, Yimer, Habte A, Wildgoose, Peter, Burton, Paul, Vijapurkar, Ujjwala, Kaul, Simrati, Eikelboom, John, McBane, Robert, Bauer, Kenneth A, Kuderer, Nicole M, Lyman, Gary H
Published in The New England journal of medicine (21.02.2019)
Published in The New England journal of medicine (21.02.2019)
Get full text
Journal Article
Rivaroxaban thromboprophylaxis in ambulatory patients with pancreatic cancer: Results from a pre‐specified subgroup analysis of the randomized CASSINI study
Vadhan‐Raj, Saroj, McNamara, Mairéad G., Venerito, Marino, Riess, Hanno, O'Reilly, Eileen M., Overman, Michael J., Zhou, Xiao, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Khorana, Alok A.
Published in Cancer medicine (Malden, MA) (01.09.2020)
Published in Cancer medicine (Malden, MA) (01.09.2020)
Get full text
Journal Article
Assessing Full Benefit of Rivaroxaban Prophylaxis in High-Risk Ambulatory Patients with Cancer: Thromboembolic Events in the Randomized CASSINI Trial
Khorana, Alok A., McNamara, Mairéad G., Kakkar, Ajay K., Streiff, Michael B., Riess, Hanno, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Soff, Gerald A.
Published in TH open : companion journal to thrombosis and haemostasis (01.04.2020)
Published in TH open : companion journal to thrombosis and haemostasis (01.04.2020)
Get full text
Journal Article
Identification and Pretherapy Susceptibility of Pathogens in Patients with Complicated Urinary Tract Infection or Acute Pyelonephritis Enrolled in a Clinical Study in the United States from November 2004 Through April 2006
Peterson, Janet, PhD, Kaul, Simrati, PhD, Khashab, Mohammed, MBA, Fisher, Alan, DrPH, Kahn, James B., MD
Published in Clinical therapeutics (01.10.2007)
Published in Clinical therapeutics (01.10.2007)
Get full text
Journal Article
Does early detection of atrial fibrillation reduce the risk of thromboembolic events? Rationale and design of the Heartline study
Gibson, C. Michael, Steinhubl, Steven, Lakkireddy, Dhanunjaya, Turakhia, Mintu P., Passman, Rod, Jones, W. Schuyler, Bunch, T. Jared, Curtis, Anne B., Peterson, Eric D., Ruskin, Jeremy, Saxon, Leslie, Tarino, Michael, Tarakji, Khaldoun G., Marrouche, Nassir, Patel, Mithun, Harxhi, Ante, Kaul, Simrati, Nikolovski, Janeta, Juan, Stephanie, Wildenhaus, Kevin, Damaraju, C.V., Spertus, John A.
Published in The American heart journal (01.05.2023)
Published in The American heart journal (01.05.2023)
Get full text
Journal Article
A Double-Blind, Randomized Comparison of Levofloxacin 750 mg Once-Daily for Five Days With Ciprofloxacin 400/500 mg Twice-Daily for 10 Days for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Peterson, Janet, Kaul, Simrati, Khashab, Mohammed, Fisher, Alan C, Kahn, James B
Published in Urology (Ridgewood, N.J.) (2008)
Published in Urology (Ridgewood, N.J.) (2008)
Get full text
Journal Article
Rivaroxaban thromboprohylaxis in ambulatory patients with pancreatic cancer: Results from a prespecified subgroup analysis of the CASSINI study
Vadhan-Raj, Saroj, McNamara, Mairead Geraldine, Venerito, Marino, Riess, Hanno, O'Reilly, Eileen Mary, Overman, Michael J., Zhou, Xiao, Vijapurkar, Ujjwala, Kaul, Simrati, Wildgoose, Peter, Khorana, Alok A.
Published in Journal of clinical oncology (20.05.2019)
Published in Journal of clinical oncology (20.05.2019)
Get full text
Journal Article
Rivaroxaban Thromboprophylaxis in High-Risk Ambulatory Cancer Patients Receiving Systemic Therapy: Results of a Randomized Clinical Trial (CASSINI)
Khorana, Alok A., Soff, Gerald A., Kakkar, Ajay K., Vadhan-Raj, Saroj, Riess, Hanno, Wun, Ted, Streiff, Michael B., Garcia, David A., Liebman, Howard A., Belani, Chandra, O'Reilly, Eileen M., Patel, Jai N, Yimer, Habte A., Wildgoose, Peter, Burton, Paul, Vijapurkar, Ujjwala, Kaul, Simrati, Eikelboom, John, McBane, Robert D., Bauer, Kenneth A., Kuderer, Nicole M., Lyman, Gary H.
Published in Blood (29.11.2018)
Published in Blood (29.11.2018)
Get full text
Journal Article
A trial of levofloxacin 750 mg once daily for 5 days versus ciprofloxacin 400 mg and/or 500 mg twice daily for 10 days in the treatment of acute pyelonephritis
Klausner, Howard A., Brown, Patricia, Peterson, Janet, Kaul, Simrati, Khashab, Mohammed, Fisher, Alan C., Kahn, James B.
Published in Current medical research and opinion (01.11.2007)
Published in Current medical research and opinion (01.11.2007)
Get full text
Journal Article